Viewing Study NCT05993702


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-06-13 @ 6:18 AM
Study NCT ID: NCT05993702
Status: UNKNOWN
Last Update Posted: 2023-08-15
First Post: 2023-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
Sponsor: China Medical University, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None TAS 102 View
None Regorafenib View
None Fruquintinib View
None Gastrointestinal Tumours View
Keywords: